Y. Shigeta

GLUCOSE, INSULIN AND SOMATOSTATIN INFUSION FOR THE DETERMINATION OF INSULIN SENSITIVITY

Y. Harano, S Ohgaku, Hideki Hidaka et al. · The Journal of Clinical Endocrinology & Metabolism · 1977 · 151 citations

Medicine, Endocrinology, Pharmacology +17

Effects of a new aldose reductase inhibitor on various tissues in vitro.

Hiroshi Terashima, K. Hama, Reiko Yamamoto et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 137 citations

Life Sciences, Biochemistry, Pharmacology +9

Long‐term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy

Norio Hotta, Ryuzo Kawamori, Masakatsu Fukuda et al. · Diabetic Medicine · 2012 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Abnormal glutathione metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium

Atsunori Kashiwagi, T. Asahina, M. Ikebuchi et al. · Diabetologia · 1994 · 123 citations

Life Sciences, Biochemistry, Cell Biology +16

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

Ryuichi Kikkawa, Ikuo Hatanaka, H. Yasuda et al. · Diabetologia · 1983 · 112 citations · Full text

Medicine, Neuroscience, Pharmacology +10